Here Are Monday’s Top Wall Street Analyst Research Calls: Adobe, Biogen, First Solar, GoDaddy, Hubspot, Palantir Technologies, Robinhood Markets, Snowflake, TeraWulf, T-Mobile US and More
Wall Street analysts issued updates on multiple companies. Biogen (BIIB) was upgraded to Overweight with a $300 target, First Solar (FSLR) to Buy with a $270 target, and Salesforce (CRM) to Buy with a $285 target. Adobe (ADBE) was downgraded to Underweight with a $225 target, and Snowflake (SNOW) to Accumulate with a $515 target. Robinhood (HOOD) was initiated with an Outperform rating and $130 target.
How this was made
The 30-second read
Why it matters
The mixed rating changes provide modest trading ideas but lack a single, material catalyst.
Market read
Analyst rating updates generate short-term price pressure for individual stocks but do not constitute a major market mover.
What to watch
Potential macro headwinds and upcoming earnings season could dampen the impact of these rating changes.
Background
The article lists recent analyst upgrades, downgrades, and initiations across multiple U.S.-listed companies.
Ticker impact
BIIB upgraded to Overweight with a new $300 price target, indicating potential upside.
likely upward pressure as investors price in the higher target
Upgrade to Overweight and a 43% target increase can attract buying.
FSLR raised to Buy with a $270 target, implying bullish outlook.
upward pressure from buy-side interest
Upgrade and target raise signal improved fundamentals.
CRM double upgraded to Buy, target lifted to $285.
likely price rise as investors react to the upgrade
Double upgrade reflects strong confidence from Bank of America.
TMUS upgraded to Outperform with a $170 target.
moderate upward pressure
Target increase signals better earnings expectations.
TYL upgraded to Overweight, target raised to $400.
upward pressure from institutional buying
Significant target hike reflects confidence in earnings.
ADBE downgraded to Underweight, target cut to $225.
downward pressure as investors reassess valuation
Target cut of 17% signals weaker outlook.
GDDY downgraded to Sector Perform, target unchanged at $95.
potential modest decline
Sector Perform rating reduces relative attractiveness.
HUBS cut to Equal Weight, target unchanged at $240.
limited impact, possible slight downside
Target unchanged, but rating downgrade signals caution.
Market effects
Analyst rating changes may slightly shift sector sentiment for biotech, solar, cloud, telecom, and fintech.
Primarily U.S. market impact; no specific regional effect.
Limited global relevance beyond the listed companies.
Counterpoint
Investors may view the upgrades as premature if broader market conditions remain volatile.
Key entities
- AnalystJPMorgan
Provided upgrade to Biogen.
- AnalystWells Fargo
Upgraded Adobe and Tyler Technologies.
